Updates are available Correction dated 2023-05-30
Click to view Correction: https://doi.org/10.1038/s41467-023-38931-6
-
Authors
Niborski, Leticia Laura
Gueguen, Paul http://orcid.org/0000-0003-2930-6073
Ye, Mengliang
Thiolat, Allan
Ramos, Rodrigo Nalio
Caudana, Pamela http://orcid.org/0000-0002-1737-0476
Denizeau, Jordan
Colombeau, Ludovic
Rodriguez, Raphaël http://orcid.org/0000-0001-7668-446X
Goudot, Christel
Luccarini, Jean-Michel
Soudé, Anne
Bournique, Bruno
Broqua, Pierre
Pace, Luigia
Baulande, Sylvain http://orcid.org/0000-0003-3104-1684
Sedlik, Christine http://orcid.org/0000-0001-8502-0905
Quivy, Jean-Pierre http://orcid.org/0000-0001-6557-7204
Almouzni, Geneviève http://orcid.org/0000-0001-5570-0723
Cohen, José L. http://orcid.org/0000-0002-5077-6726
Zueva, Elina
Waterfall, Joshua J. http://orcid.org/0000-0002-3762-5050
Amigorena, Sebastian http://orcid.org/0000-0001-8583-8416
Piaggio, Eliane http://orcid.org/0000-0002-2455-8442
- License Information
-
More Information
Article History
Received: 8 December 2020
Accepted: 18 June 2022
First Online: 29 June 2022
Change Date: 30 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-38931-6
Competing interests
: S.A., J.W., and E.P. are shareholders in Mnemo Therapeutics. P.B. and A.S. are employees and shareholders in Inventiva Pharma. The other authors declare no competing interests.
